Glucocorticoids in Leprosy Reversal reaction
Leprosy is a disease that is caused by Mycobacterium leprae which results in lots of disabilities in the patients. Leprosy is treated by multi-drug therapy regimen; however, this therapy might cause leprosy reactions in the patients. There are several types of lepromatous reaction: type 1 reaction,...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2019-09-01
|
Series: | Serbian Journal of Dermatology and Venereology |
Subjects: | |
Online Access: | https://doi.org/10.2478/sjdv-2019-0011 |
id |
doaj-1d7974f449a34bbe81ec2248af0eef67 |
---|---|
record_format |
Article |
spelling |
doaj-1d7974f449a34bbe81ec2248af0eef672021-09-05T14:01:55ZengSciendoSerbian Journal of Dermatology and Venereology1821-09022406-06312019-09-01113778310.2478/sjdv-2019-0011sjdv-2019-0011Glucocorticoids in Leprosy Reversal reactionYuniati Renni0Khrisna Matthew Brian1Department of Dermatology and Venereology, Diponegoro University, Semarang, IndonesiaDepartment of Dermatology and Venereology, Diponegoro University, Semarang, IndonesiaLeprosy is a disease that is caused by Mycobacterium leprae which results in lots of disabilities in the patients. Leprosy is treated by multi-drug therapy regimen; however, this therapy might cause leprosy reactions in the patients. There are several types of lepromatous reaction: type 1 reaction, type 2 reaction and neuritis. Type 1 reaction mainly occurs in BB, BL and BT forms of leprosy and is characterized by exacerbation of preexisting lesions. The therapy of this reaction according to the WHO guideline is corticosteroid therapy. This article will explain several key points related to the corticosteroid therapy in leprosy reversal reactions, including the side effects and alternative therapies available.https://doi.org/10.2478/sjdv-2019-0011leprosygene expression profilingglucocorticoidscomorbiditydiagnosisprednisoloneindonesia |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yuniati Renni Khrisna Matthew Brian |
spellingShingle |
Yuniati Renni Khrisna Matthew Brian Glucocorticoids in Leprosy Reversal reaction Serbian Journal of Dermatology and Venereology leprosy gene expression profiling glucocorticoids comorbidity diagnosis prednisolone indonesia |
author_facet |
Yuniati Renni Khrisna Matthew Brian |
author_sort |
Yuniati Renni |
title |
Glucocorticoids in Leprosy Reversal reaction |
title_short |
Glucocorticoids in Leprosy Reversal reaction |
title_full |
Glucocorticoids in Leprosy Reversal reaction |
title_fullStr |
Glucocorticoids in Leprosy Reversal reaction |
title_full_unstemmed |
Glucocorticoids in Leprosy Reversal reaction |
title_sort |
glucocorticoids in leprosy reversal reaction |
publisher |
Sciendo |
series |
Serbian Journal of Dermatology and Venereology |
issn |
1821-0902 2406-0631 |
publishDate |
2019-09-01 |
description |
Leprosy is a disease that is caused by Mycobacterium leprae which results in lots of disabilities in the patients. Leprosy is treated by multi-drug therapy regimen; however, this therapy might cause leprosy reactions in the patients. There are several types of lepromatous reaction: type 1 reaction, type 2 reaction and neuritis. Type 1 reaction mainly occurs in BB, BL and BT forms of leprosy and is characterized by exacerbation of preexisting lesions. The therapy of this reaction according to the WHO guideline is corticosteroid therapy. This article will explain several key points related to the corticosteroid therapy in leprosy reversal reactions, including the side effects and alternative therapies available. |
topic |
leprosy gene expression profiling glucocorticoids comorbidity diagnosis prednisolone indonesia |
url |
https://doi.org/10.2478/sjdv-2019-0011 |
work_keys_str_mv |
AT yuniatirenni glucocorticoidsinleprosyreversalreaction AT khrisnamatthewbrian glucocorticoidsinleprosyreversalreaction |
_version_ |
1717809373522165760 |